On-demand treatment with deucrictibant, an experimental oral small molecule in the pipeline at Pharvaris, provides rapid relief from sudden swelling due to hereditary angioedema (HAE) and, when taken daily for up to three years, can reduce the frequency of attacks over the long term. That’s according to…